Welcome to our dedicated page for Bridgewater Bancshares SEC filings (Ticker: BWB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bridgewater Bancshares, Inc. filings document the regulatory record of a Nasdaq-listed Minnesota financial holding company and its wholly owned banking subsidiary, Bridgewater Bank. Form 8-K reports cover operating results, earnings presentations, Regulation FD investor materials, cash dividend announcements and material agreements such as the company's at-the-market common stock equity distribution arrangement.
Proxy and shareholder-meeting filings address board elections, voting results, executive compensation, equity awards and other governance matters. The filing record also reflects capital-structure disclosures for common stock and depositary-share securities, formal financial-condition disclosures and capital management matters tied to the Bridgewater Bank operating model.
Bridgewater Bancshares Inc (BWB) director Thomas P. Trutna reported a non-derivative acquisition of company stock on 09/30/2025. The Form 4 shows an acquisition of 582 shares with a reported price of $0, resulting in 95,078 shares beneficially owned directly after the transaction. The filing was executed by an attorney-in-fact, Ben Klocke, and dated 10/01/2025.
This disclosure identifies the reporting person as a director and indicates the Form 4 was filed by one reporting person. No derivative transactions or additional explanatory detail are included in the form.
James S. Johnson, a director of Bridgewater Bancshares Inc (BWB), reported an acquisition of 1,164 shares of the company's common stock on 09/30/2025. The Form 4 shows 98,947 shares beneficially owned following the reported transaction on a direct basis. The filing also discloses indirect holdings of 59,250 shares held by the James S. Johnson Trust, 76,750 shares held by the Jolynn Johnson Trust, and 10,417 shares held in a spouse IRA, with shared voting and investment power noted for the trusts. The transaction is recorded at a price of $0 on the form. The form is signed by Ben Klocke, Attorney-in-Fact, dated 10/01/2025.
Bridgewater Bancshares Inc (BWB) director Todd B. Urness reported an open-market purchase of 1,164 shares on 09/30/2025 at no reported cash price, bringing his total beneficial ownership to 1,173,722 shares. The filing was signed by an attorney-in-fact on 10/01/2025. The transaction is recorded on a Form 4 and reflects a director-level acquisition disclosed under Section 16.
David B. Juran, a director of Bridgewater Bancshares Inc (BWB), reported a non‑derivative acquisition of 1,164 shares of common stock on 09/30/2025 at a reported price of $0. After the transaction he is shown as beneficially owning 1,346,708 shares directly and holds additional indirect interests through multiple trusts: 10,725, 95,307, 16,328, and 121,301 shares under various trustee or attorney‑in‑fact arrangements. The filing clarifies the nature of each indirect holding and lists an attorney‑in‑fact signature dated 10/01/2025.
Jessica Anne Stejskal, listed at a Bridgewater Bancshares, Inc. address in St. Louis Park, MN, filed an initial Form 3 reporting her role as Chief Experience Officer and a director of Bridgewater Bancshares Inc [BWB]. The filing, dated for the event 09/15/2025 and signed by attorney-in-fact Ben Klocke on 09/18/2025, shows 12,961 shares of common stock owned directly. It also discloses three option grants held directly: an option covering 1,600 shares (exercisable 09/30/2017 at $7.47), an option covering 10,000 shares (related to an 08/01/2023 grant with $10.65 exercise price), and an option covering 25,000 shares (related to a 02/03/2025 grant with $13.78 exercise price). Vesting schedules are described in the filing as incremental vesting from the grant dates under the 2017 and 2023 equity plans.
Katie Lynn Morrell, Chief Credit Officer and director at Bridgewater Bancshares Inc, reported direct ownership of 10,441 shares of the issuer's common stock and two stock option grants. The first option covers 10,000 shares with an exercise price of $10.65; the second covers 25,000 shares with an exercise price of $13.78. Both options vest in 25% increments over four anniversaries of their respective grant dates. All holdings and derivative securities are reported as direct beneficial ownership.